Focus Partners Wealth
BBNX icon

Focus Partners Wealth’s Beta Bionics BBNX Stock Holding History

Focus Partners Wealth’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$179K Buy
+11,428
New +$136K ﹤0.01% 2534
2026
Q1 		– Sell
-10,663
Closed -$325K – 2859
2025
Q4 		$325K Sell
10,663
-1,063
-9% -$28.4K ﹤0.01% 2177
2025
Q3 		$233K Buy
+11,726
New +$206K ﹤0.01% 1977

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Focus Partners Wealth's BBNX Position: Q2 2026 in Review

Focus Partners Wealth opened a new position in Beta Bionics (BBNX) in Q2 2026: 11,428 shares worth $179K. The stake represents ﹤0.01% of the portfolio and ranks #2534 among its holdings. This is a return to the name: Focus Partners Wealth previously reported a position in BBNX as recently as Q4 2025.

Focus Partners Wealth first reported a position in BBNX in Q3 2025 and has held it in 3 quarters since. The position peaked at $325K in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Focus Partners Wealth held 11,428 shares of Beta Bionics worth $179K as of Q2 2026.
  • Beta Bionics was a new Focus Partners Wealth position in Q2 2026.
  • Beta Bionics made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2534 holding.
  • Focus Partners Wealth first reported a position in Beta Bionics in Q3 2025 and has held it in 3 quarters since.
  • Focus Partners Wealth's Beta Bionics position peaked at $325K in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.